More than 240 companies across the globe claim to have the required capabilities >>>

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers.
To order this 375+ page report, which features 180+ figures and 195+ tables, please visit this link
The USD 1.7 billion financial opportunity (by 2030) within the ophthalmic drugs contract manufacturing market has been analyzed across the following segments:
Type of product
  • Ophthalmic API
  • Ophthalmic drug FDF
  • Type of FDF manufactured
  • Solid
  • Semi-solid
  • Liquid / suspension
Type of primary packaging
Ampoule / vial 
Glass / plastic bottle
Ointment tube
Blister packing
Other forms
Scale of manufacturing
  • Clinical
  • Commercial
Company size
  • Small
  • Mid-sized
  • Large
  • Very large
Target disease indication
  • Age-related macular degeneration
  • Dry eye
  • Glaucoma
  • Other disease segments
Key geographical regions
  • North America (US, Canada and Mexico)
  • Europe (UK, Germany, France, Spain, Italy and rest of Europe)
  • Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
  • Rest of the world
The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 report features the following companies, which we identified to be key players in this domain: 
  • Akorn
  • Akums
  • Bal Pharma
  • Catalent
  • Cayman Chemical
  • Entod Pharmaceuticals
  • Farmigea
  • Glenmark Pharmaceuticals
  • Indiana Ophthalmics
  • Lomapharm
  • Medichem
  • Pillar5 Pharma
  • Recipharm
  • Salvat
  • Sterling Pharmaceutical Services
  • Sunways India
Table of Contents
1. Preface

2. Executive Summary

3. Introduction


4. Current Market Landscape


5. Company Competitiveness Analysis


6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles


7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles


8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles


9. Clinical Trial Analysis


10. Capacity Analysis


11. Demand Analysis


12. Market Forecast


13. Case Study: Comparison of Small Molecule and Large Molecule Ophthalmic Drugs / Therapies


14. SWOT Analysis
15. Survey Analysis
 
16. Executive Insights
 
17. Future Growth Opportunities
 
18. Appendix 1: List of Ophthalmic Medical Device Contract Manufacturers
19. Appendix 2: Tabulated Data
20. Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
763 Posts

Made with by Mamby